NCI Professional Judgment Budget, President's Budget and Appropriations
Professional Judgment Budget, President’s Budget, and Enacted Appropriations Comparison
This graph displays a historical view of the Professional Judgment Budget, the President's Budget, and the Enacted Appropriations for NCI from fiscal years 1974 through 2025. The National Cancer Act gives the NCI director special authority to submit an annual Professional Judgment Budget, sometimes referred to as the "Bypass Budget," directly to the President and Congress. This budget reflects NCI cancer research priorities and identifies areas of potential investment in cancer research. The President's Budget is an annual report prepared by the White House, and in coordination with federal agencies, proposing funding levels for the federal government, including for NIH and NCI, according to the President's priorities. Congress reviews the Professional Judgment Budget and the President's Budget, and then conducts its own inquiries and hearings to develop and pass an appropriations bill to fund the government. When the bill is signed into law by the President, the Enacted Appropriation levels become available for NCI's cancer research activities.
| FY | Professional Judgement Budget* | President's Budget* | Enacted Appropriation* |
|---|---|---|---|
| 1974 | 640,031 | 500,000 | 551,192 |
| 1975 | 750,000 | 600,000 | 691,666 |
| 1976 | 898,500 | 605,000 | 914,628 |
| 1977 | $948,000 | 687,670 | 815,000 |
| 1978 | 955,000 | 818,936 | 872,388 |
| 1979 | 1,036,000 | 878,802 | 937,129 |
| 1980 | 1,055,000 | 936,958 | 1,000,000 |
| 1981 | 1,170,000 | 1,007,800 | 989,355 |
| 1982 | 1,192,000 | 1,025,946 | 986,617 |
| 1983 | 1,197,000 | 955,449 | 987,642 |
| 1984 | 1,074,000 | 986,681 | 1,081,581 |
| 1985 | 1,189,000 | 916,485 | 1,183,806 |
| 1986 | 1,460,000 | 1,126,012 | 1,264,159 |
| 1987 | 1,570,000 | 1,158,089 | 1,402,837 |
| 1988 | 1,700,000 | 1,302,823 | 1,469,327 |
| 1989 | 2,080,000 | 1,468,256 | 1,593,536 |
| 1990 | 2,195,000 | 1,494,741 | 1,664,000 |
| 1991 | 2,410,000 | 1,694,059 | 1,766,324 |
| 1992 | 2,612,000 | 1,810,230 | 1,989,278 |
| 1993 | 2,775,000 | 2,010,439 | 2,007,483 |
| 1994 | 3,200,000 | 2,142,122 | 2,082,267 |
| 1995 | 3,600,000 | 1,967,709 | 2,135,119 |
| 1996 | 3,640,000 | 1,994,007 | 2,251,084 |
| 1997 | 2,977,000 | 2,060,392 | 2,382,532 |
| 1998 | 2,702,500 | 2,217,482 | 2,547,314 |
| 1999 | 3,191,000 | 2,528,760 | 2,927,187 |
| 2000 | 3,873,000 | 2,732,795 | 3,332,317 |
| 2001 | 4,135,000 | 3,249,730 | 3,757,242 |
| 2002 | 5,030,000 | 4,177,203 | 4,190,405 |
| 2003 | 5,690,000 | 4,673,510 | 4,622,394 |
| 2004 | 5,986,000 | 4,770,519 | 4,770,519 |
| 2005 | 6,211,000 | 4,870,025 | 4,865,525 |
| 2006 | 6,170,000 | 4,841,774 | 4,841,774 |
| 2007 | 5,949,714 | 4,753,609 | 4,797,639 |
| 2008 | 5,865,788 | 4,782,114 | 4,890,525 |
| 2009 | 6,028,386 | 4,809,819 | 4,968,973 |
| 2010 | 7,193,393 | 5,150,170 | 5,103,388 |
| 2011 | 6,199,666 | 5,264,643 | 5,103,388 |
| 2012 | 5,869,857 | 5,196,136 | 5,081,788 |
| 2013 | 5,833,010 | 5,068,864 | 5,072,183 |
| 2014 | 5,125,951 | 4,923,238 | |
| 2015 | 4,930,715 | 4,950,396 | |
| 2016 | 5,754,000 | 5,098,479 | 5,214,701 |
| 2017 | 5,453,000 | 5,893,509 | 5,689,329 |
| 2018 | 4,474,222 | 5,964,800 | |
| 2019 | 6,380,000 | 5,626,312 | 6,143,892 |
| 2020 | 6,522,000 | 5,246,737 | 6,440,442 |
| 2021 | 6,928,000 | 5,881,173 | 6,559,852 |
| 2022 | 7,609,000 | 6,733,302 | 6,912,522 |
| 2023 | 7,766,000 | 6,713,851 | 7,320,159 |
| 2024 | 9,988,000 | 7,820,159 | |
| 2025 | 11,466,000 | 7,839,141 | |
| * Dollars in thousands | |||
- The Professional Judgment Budget was not released in fiscal years 2014, 2015, or 2018. To learn more about this authority and view the budget archive, please visit NCI's About the Annual Plan and Budget Proposal page.
- The fiscal years 2017 and 2018 Enacted Appropriated budget includes $300,000,000 of Cancer Moonshot℠ funding. $680,000,000 and $300,000,000 of Cancer Moonshot℠ funding are also included in the fiscal years 2017 and 2018 President’s Budget. $400,000,000, $195,000,000, $195,000,000 of Cancer Moonshot℠ funding are included in the fiscal years 2019, 2020, and 2021 Enacted Appropriated levels, respectively. The Professional Judgment Budget and President’s Budget also includes $400,000,000, $195,000,000, $195,000,000, $194,000,000 and $216,000,000 of Cancer Moonshot℠ funding in fiscal years 2019, 2020, 2021, 2022, and 2023, respectively.
- The Enacted Appropriation levels do not include potential adjustments such as Rescissions, Sequestrations, Supplemental funding, or Secretary's Transfers that may have impacted the amount available for NCI expenditure.
NCI Appropriations
NCI receives its budget from the United States Congress as part of the federal budget process for the Department of Health and Human Services and NIH.
The NCI budget for fiscal year 2021 (October 1, 2020 through September 30, 2021) is $6.56 billion. During the period from 2010 through 2021, the NCI budget averaged $5.52 billion per year.
The NCI budget for fiscal year 2022 (October 1, 2021 through September 30, 2022) is $6.91 billion. During the period from 2010 through 2022, the NCI budget averaged $5.62 billion per year.
The NCI budget for fiscal year 2023 (October 1, 2022 through September 30, 2023) is $7.32 billion. During the period from 2010 through 2023, the NCI budget averaged $5.75 billion per year.
| Fiscal Years | Amount | Notes |
|---|---|---|
| 1938–2002 | $52,940,982,220 | |
| 2003 | $4,622,394,000 | Prior to reductions in PL 108-7 (-$30,046,000 for the enacted rescission and $2,000 lapse). Includes $263,442,000 of AIDS funding. |
| 2004 | $4,770,519,000 | Prior to reductions in PL 108-199 (-$3,136,000 for Labor/HHS/ED rescission; $28,128,000 for across the board reduction; -$15,357,000 NIH 1% transfer assessment, and $5,000 lapse). Includes $266,975,000 of AIDS funding. |
| 2005 | $4,865,525,000 | Prior to reductions in PL 108-447 ($38,914,000 .8% across the board reduction; -$1,353,000 for Labor/HHS/ED rescission; -$30,505,000 NIH 1% transfer assessment, and $9,000 lapse). Includes $265,907,000 of AIDS funding. |
| 2006 | $4,841,774,000 | Prior to reductions in PL 109-149 (-$48,418,000 for Labor/HHS/ED rescission; -$3,293,000 HHS transfer for CMS activities; -$42,834,000 NIH 1% transfer for roadmap activities, and $4,000 lapse). Includes $253,866,000 of AIDS funding. |
| 2007 | $4,797,639,000 | Prior to reductions in PL 110-5 (-$5,015,000 NIH transfer for GEI activities, and $9,000 lapse). Includes $253,866,000 of AIDS funding. |
| 2008 | $4,890,525,000 | Prior to -$85,437,000 rescission and $3,091,000 in NIH transfer activities. Includes supplemental appropriation of $25,559,000. Includes $258,499,000 of AIDS funding. |
| 2009 | $4,968,973,000 | Prior to reductions in PL 111-8 (-$2,042,631 NIH transfer for activities, and $4,000 lapse). Includes $265,882,000 of AIDS funding. |
| 2010 | $5,103,388,000 | Prior to -$760,000 HHS Secretary's Transfer, -$4,459,000 in NIH transfer for activities, and $22,000 lapse. Includes $272,130,000 of AIDS funding. |
| 2011 | $5,103,388,000 | Prior to -$44,810,787 recission and $472,000 lapse. Includes $269,953,000 of AIDS funding. |
| 2012 | $5,081,788,000 | Prior to $9,605,579 rescission, -$1,445,000 HHS Secretary's Transfer ,-$3,342,000 HHS Secretary's Transfer for Alzheimer's research, and $54,000 lapse. Includes $271,692,000 of AIDS funding. |
| 2013 | $5,072,183,000 | Prior to -$254,589,000 under sequestration (Budget Control Act, 2011, PL 112–25), -$10,144,367 recission, -$28,044,000 HHS Secretary's Transfer and +$9,714,000 restored from the National Children's Study and National Eye Institute HIV/AIDS funding, and $106,000 lapse. Includes $261,550,000 of AIDS funding. |
| 2014 | $4,923,238,000 | Prior to -$12,359,000 HHS Secretary's Transfer,-$965,000 HHS Secretary’s Cybersecurity Transfer (authorized by section 206 of PL 113-76), +$16,180,552 transfer from National Children's Study, and +$6,307,000 transfer from NIH Office of AIDS Research, and $33,000 lapse. Includes $269,212,000 of AIDS funding. |
| 2015 | $4,950,396,000 | Prior to +$2,632,000 transfer from NIH Office of AIDS Research and $435,000 lapse. Includes $269,660,000 of AIDS funding. |
| 2016 | $5,214,701,000 | Prior to -$7,217,390 HHS Secretary's Transfer, -$1,192,000 transfer to NIH Office of AIDS Research, and $122,000 lapse. Includes $266,422,000 of AIDS funding. |
| 2017 | $5,689,329,000 | Prior to -$11,971,000 HHS Secretary's Transfer, -$17,403,000 transfer to NIH Office of AIDS Research, and $247,000 lapse. Includes $249,019,000 of AIDS funding and $300,000,000 of Cancer Moonshot℠ funding. |
| 2018 | $5,964,800,000 | Prior to -$13,309,000 HHS Secretary's Transfer, -$7,785,000 transfer to NIH Office of AIDS Research, and $250,000 lapse. Includes $241,234,000 of AIDS funding and $300,000,000 of Cancer Moonshot℠ funding. |
| 2019 | $6,143,892,000 | Prior to -$19,730,000 HHS Secretary's Transfer, -$2,874,000 transfer to NIH Office of AIDS Research, and $252,786 lapse. Includes $241,979,000 of AIDS funding and $400,000,000 of Cancer Moonshot℠ funding. |
| 2020 | $6,440,442,000 | Prior to -$4,000 transfer to NIH Office of AIDS Research and $254,618 lapse. Includes $241,975,000 of AIDS funding and $195,000,000 of Cancer Moonshot℠ funding. |
| 2021 | $6,559,852,000 | Prior to -$1,047,000 transfer to NIH Office of AIDS Research, Secretary's Transfer -$19,109,000, and $289,223 lapse. Includes $240,513,000 of AIDS funding, and $195,000,000 of Cancer Moonshot℠ funding. |
| 2022 | $6,912,522,000 | Prior to -$2,896,000 transfer to NIH Office of AIDS Research and $248,297 lapse. Includes $248,940,000 of AIDS funding, and $194,000,000 of Cancer Moonshot℠ funding. |
| 2023 | $7,320,159,000 | Prior to -$2,918,000 transfer to NIH Office of AIDS Research, and $234,418 lapse. Includes $256,734,000 of AIDS funding, and $216,000,000 of Cancer Moonshot℠ funding. |
| 1938–2023 | $167,178,409,220 |